Results 11 to 20 of about 1,106,140 (286)

IL-33 in Rheumatic Diseases [PDF]

open access: yesFrontiers in Medicine, 2021
Interleukin-33 (IL-33) is a nuclear factor mainly expressed in barrier epithelium, endothelial cells, and fibroblast reticular cells. Some inflammatory cells also express IL-33 under certain conditions.
Yuanji Dong, Jixin Zhong, Lingli Dong
doaj   +3 more sources

IL-33 in Mental Disorders [PDF]

open access: yesMedicina, 2021
Mental disorders are common in the general population; every year about 25% of the total European population is affected by a mental condition. The prevalence of psychiatric disorders might be underestimated.
Gianluca Pandolfo   +6 more
doaj   +4 more sources

IL-33 and IL-33-derived DC-based tumor immunotherapy

open access: yesExperimental and Molecular Medicine
Interleukin-33 (IL-33), a member of the IL-1 family, is a cytokine released in response to tissue damage and is recognized as an alarmin. The multifaceted roles of IL-33 in tumor progression have sparked controversy within the scientific community ...
Myeong-Ho Kang, Yong-Soo Bae
doaj   +3 more sources

Blockade of IL‐33 signalling attenuates osteoarthritis [PDF]

open access: yesClinical & Translational Immunology, 2020
Objectives Osteoarthritis (OA) is the most common form of arthritis characterised by cartilage degradation, synovitis and pain. Disease modifying treatments for OA are not available.
Zengliang He   +7 more
doaj   +3 more sources

IL-33 Raises Alarm [PDF]

open access: yesImmunity, 2009
The interleukin-1 (IL-1)-like cytokine IL-33 is widely assumed to undergo proteolytic maturation by caspase-1. In this issue of Immunity, Lüthi et al. (2009) show that IL-33 is not a caspase-1 substrate. IL-33 is inactivated by caspase-3 and -7 to prevent an inappropriate immune response during apoptosis, but not in necrosis.
Lamkanfi, Mohamed, Dixit, Vishva M.
openaire   +2 more sources

IL-33 and Airway Inflammation [PDF]

open access: yesAllergy, Asthma and Immunology Research, 2011
Interleukin-33 (IL-33) is the 11th member of IL-1 cytokine family which includes IL-1 and IL-18. Unlike IL-1β and IL-18, IL-33 is suggested to function as an alarmin that is released upon endothelial or epithelial cell damage and may not enhance acquired immune responses through activation of inflammasome.
Oboki, Keisuke   +3 more
openaire   +2 more sources

IL-33 Exacerbates Acute Kidney Injury [PDF]

open access: yesJournal of the American Society of Nephrology, 2011
Inflammation contributes to the pathogenesis of acute kidney injury (AKI). IL-33 is a proinflammatory cytokine, but its role in AKI is unknown. Here we observed increased protein expression of full-length IL-33 in the kidney following induction of AKI with cisplatin.
Ali, Akcay   +12 more
openaire   +2 more sources

IL-33 and IL-33 Receptors in Host Defense and Diseases

open access: yesAllergology International, 2010
Interleukin-33 (IL-33) is a member of the IL-1 cytokine family, which includes IL-1 and IL-18. IL-33 is considered to be crucial for induction of Th2-type cytokine-associated immune responses such as host defense against nematodes and allergic diseases by inducing production of such Th2-type cytokines as IL-5 and IL-13 by Th2 cells, mast cells ...
Oboki, Keisuke   +4 more
openaire   +2 more sources

The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity

open access: yesFrontiers in Immunology, 2018
Interleukin-33 (IL-33) is a IL-1 family member of cytokines exerting pleiotropic activities. In the steady-state, IL-33 is expressed in the nucleus of epithelial, endothelial, and fibroblast-like cells acting as a nuclear protein.
Claudia Afferni   +11 more
doaj   +1 more source

Serum IL-5, POSTN and IL-33 levels in chronic rhinosinusitis with nasal polyposis correlate with clinical severity

open access: yesBMC Immunology, 2022
Background Chronic rhinosinusitis (CRS) is a group of heterogeneous diseases characterized by epithelial inflammation and tissue eosinophilic infiltration.
Hanna Zielińska-Bliźniewska   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy